Ronald Swerdloff
Professor-in-Residence · University of Southern California/Los Angeles General Medical Center
Credentials: · · · ·
History
- 1965–1967
Endocrinology, Diabetes, and Metabolism
- 1962–1965
Internal Medicine
Research
Review · The Journal of Clinical Endocrinology & Metabolism · 2010 · 1,447 citations
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2018 · 1,202 citations
Radioimmunoassay of plasma progesterone
The Journal of Clinical Endocrinology & Metabolism · 1971 · 852 citations
- CW
228 papers
- SB
57 papers · 8 as a fellow
- PL
33 papers

29 papers

27 papers
- GC
24 papers

24 papers

22 papers
Grants
- 2019–2026
Center for Male Reproductive Epigenomics
National Institute of Child Health and Human Development · P50
Project lead · $1.6M · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
- 1988–2015
Endocrinology, Metabolism and Nutrition Training Grant
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $3.6M · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
- 1997–2010
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $5.5M · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
- 1986–1992
National Institute of Child Health and Human Development · P30
Contact PI · $3.3M · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Clinical trials
- 2016–2017
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
Principal investigator · Completed · Phase 2
Clarus Therapeutics, Inc.
- 2013
Safety and Efficacy Trial of Testosterone Undecanoate
Principal investigator · Completed · Phase 3
Clarus Therapeutics, Inc.
- 2012–2014
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Principal investigator · Completed · Phase 3
Clarus Therapeutics, Inc.
- 2011–2013
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Principal investigator · Completed · Phase 3
Clarus Therapeutics, Inc.



